When Mr Paterson talked about 35-40 patients by years end in interviews before I was always curious where those EXTRA patients would come from as 13 (FIH study) and 15 (EFS study) only added up to 28!
So now we have our answer.
As a side note, in all of my years reading commentary from doctors and scientists on results, I've gotten used to them describing describing even the most amazing results in restrained terms, until now....
“In the short-term, the haemodynamics are amazing, and that’s one of the things I’m excited about…"
A very strong and enthusiastic reaction here from,
Susheel Kodali, MD, Columbia University Irving Medical Center, New York, USA, first author on the publication and an Investigator in the FIH study.
I think every AVR shareholder right now should be feeling just as excited, we're onto something very very big!
AVR Price at posting:
$23.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)